what might help would be some numbers to concentrate minds… how much is E4 worth to the bottom line?
profile>signature
- Forums
- ASX - By Stock
- MYX
- Ann: NEXTSTELLIS FDA exclusivity & phase III data published
MYX
mayne pharma group limited
Add to My Watchlist
1.00%
!
$5.07

Ann: NEXTSTELLIS FDA exclusivity & phase III data published, page-12
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.07 |
Change
0.050(1.00%) |
Mkt cap ! $412.7M |
Open | High | Low | Value | Volume |
$5.00 | $5.08 | $4.94 | $475.7K | 94.87K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 538 | $5.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.08 | 1819 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 538 | 5.060 |
11 | 4656 | 5.050 |
5 | 4280 | 5.040 |
6 | 1511 | 5.030 |
3 | 1095 | 5.020 |
Price($) | Vol. | No. |
---|---|---|
5.080 | 1819 | 5 |
5.090 | 669 | 4 |
5.100 | 1181 | 3 |
5.110 | 970 | 2 |
5.120 | 1435 | 3 |
Last trade - 14.11pm 26/06/2025 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online